These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 9551957

  • 1. In SCID-hu mice, passive transfer of a humanized antibody prevents infection and atrophic change of medulla in human thymic implant due to intravenous inoculation of primary HIV-1 isolate.
    Okamoto Y, Eda Y, Ogura A, Shibata S, Amagai T, Katsura Y, Asano T, Kimachi K, Makizumi K, Honda M.
    J Immunol; 1998 Jan 01; 160(1):69-76. PubMed ID: 9551957
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA, Safrit JT, Weir R, Gauduin MC.
    Semin Immunol; 1996 Aug 01; 8(4):263-8. PubMed ID: 8883150
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals.
    Honda M, Matsuo K, Nakasone T, Okamoto Y, Yoshizaki H, Kitamura K, Sugiura W, Watanabe K, Fukushima Y, Haga S, Katsura Y, Tasaka H, Komuro K, Yamada T, Asano T, Yamazaki A, Yamazaki S.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10693-7. PubMed ID: 7479867
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.
    Steyaert S, Heyndrickx L, Verhoye L, Vermoesen T, Donners H, Fransen K, Van Wanzeele F, Vandergucht B, Vanham G, Leroux-Roels G, Vanlandschoot P.
    Antiviral Res; 2007 Aug 07; 75(2):129-38. PubMed ID: 17379323
    [Abstract] [Full Text] [Related]

  • 9. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
    Goldstein H, Pettoello-Mantovani M, Anderson CM, Cordelier P, Pomerantz RJ, Strayer DS.
    J Infect Dis; 2002 May 15; 185(10):1425-30. PubMed ID: 11992277
    [Abstract] [Full Text] [Related]

  • 10. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.
    Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA.
    Nat Med; 1997 Dec 15; 3(12):1389-93. PubMed ID: 9396610
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.
    Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA.
    Nat Med; 1999 Feb 15; 5(2):204-10. PubMed ID: 9930869
    [Abstract] [Full Text] [Related]

  • 14. Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope.
    Zolla-Pazner S, Cohen SS, Krachmarov C, Wang S, Pinter A, Lu S.
    Virology; 2008 Mar 15; 372(2):233-46. PubMed ID: 18061228
    [Abstract] [Full Text] [Related]

  • 15. Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant.
    Andrus L, Prince AM, Bernal I, McCormack P, Lee DH, Gorny MK, Zolla-Pazner S.
    J Infect Dis; 1998 Apr 15; 177(4):889-97. PubMed ID: 9534960
    [Abstract] [Full Text] [Related]

  • 16. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C, Santini SM, Logozzi M, Spada M, Andreotti M, Di Pucchio T, Parlato S, Belardelli F.
    J Exp Med; 2003 Jul 21; 198(2):361-7. PubMed ID: 12874266
    [Abstract] [Full Text] [Related]

  • 17. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 18. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K, Xin KQ, Jounai N, Kojima Y, Tamura Y, Okada E, Kawamoto S, Okuda K, Klinman D, Okuda K.
    Vaccine; 2004 Sep 09; 22(27-28):3676-90. PubMed ID: 15315847
    [Abstract] [Full Text] [Related]

  • 19. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J, Yoshimura K, Honda A, Koito A, Murakami T, Matsushita S.
    J Virol; 2007 Apr 09; 81(8):3757-68. PubMed ID: 17251298
    [Abstract] [Full Text] [Related]

  • 20. Simple i.v. inoculation of HIV-1 to Thy/Liv SCID-hu mice induce reproducible HIV infection with narrowing of medulla in human thymic implant.
    Okamoto Y, Ogura A, Shibata S, Amagai T, Katsura Y, Asano T, Honda M.
    J Vet Med Sci; 1997 Apr 09; 59(4):259-63. PubMed ID: 9152933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.